C
Chemomab Therapeutics Ltd. (CMMB)
NCM – Real vaqt narxi. Valyuta: USD
1.77
-0.06 (-3.28%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.91
+0.14 (7.91%)
Bozor oldidan: May 13, 2026, 5:43 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.77
-0.06 (-3.28%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.91
+0.14 (7.91%)
Bozor oldidan: May 13, 2026, 5:43 AM EDT
Chemomab Therapeutics Ltd., klinik bosqichdagi biotexnologiya kompaniyasi, fibroz va yallig'lanish kasalliklarini davolash uchun terapevtik vositalarni kashf qilish va ishlab chiqishga qaratilgan. Uning asosiy mahsulot nomzodi nebokitug bo'lib, bu insonlashtirilgan monoklonal antitel bo'lib, u CCL24 ning asosiy yallig'lanish va fibroz yo'llarini tartibga soluvchi asosiy funktsiyasini zaiflashtiradi, bu birlamchi sklerozli xolangitni davolash uchun 2-bosqichli klinik sinovni tugatgan, shuningdek, tizimli sklerozni davolash uchun 2-bosqichli klinik sinovda. Kompaniya 2011 yilda tashkil etilgan va Isroilning Tel-Aviv-Yafo shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Adi Mor George Ph.D. | Co-Founder, Chief Scientific Officer, CEO & Executive Director |
| Dr. David M. Weiner M.B.A., M.D. | Interim Chief Medical Officer |
| Mr. Jack Lawler | Chief Development Officer |
| Ms. Sigal Fattal CPA, M.B.A. | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | 6-K | zk2635214.htm |
| 2026-04-28 | 6-K | zk2635146.htm |
| 2026-03-23 | 20-F | zk2634510.htm |
| 2026-03-19 | 6-K | zk2634872.htm |
| 2025-11-21 | 6-K | zk2534057.htm |
| 2025-08-22 | 6-K | zk2533691.htm |
| 2025-08-14 | 6-K | zk2533584.htm |
| 2025-07-25 | 6-K | zk2533479.htm |
| 2025-07-01 | 6-K | zk2533404.htm |
| 2025-05-27 | 6-K | zk2533263.htm |